| 영문 | risk factor | 한글 | 위험인자 |
|---|---|---|---|
| 설명 | 국제방사선방호위원회(ICRP)가 1977년 권고에서 방사선방호의 목적으로 채택한 지수로, 단위선량(1 Sv)당 확률적 영향의 발생확률을 추정하여 나타낸 것이다. 생식선 선량에 대한 유전적영향의 발생률(4×10－3/Sv)이나 적색골수선량에 대한 백혈병 발생률(2×10－3/Sv)등 외에 뼈, 허파, 갑상샘, 젖샘, 기타 조직의 위험지수를 측정하여, 확률적 영향의 전신에 있어서 치사위험지수의 합계를 16.5×10－3/Sv로 하였다. 그후 ICRP는 1990년 권고에서 대상이 되는 조직과 장기를 추가하고, 수치 개정을 하면서 명칭도 각목적확률지수라고하였다. 이 권고에 의하면, 치사적 확률적 영향의 확률지수의 합계는, 일반인에 있어 60.0×10－3/Sv이다. |
||
| 영문 | official name(=generic name) | 한글 | 일반명 |
|---|---|---|---|
| 설명 | 약의 이름을 부를때 일반명과 이에 반하는 상표명(brand name: trade name)이 있다. 일반명은 약의 성분에 따라 붙이는 이름으로 비록 상표명은 달라도 그 일반명은 모두 동일할 수 있다. 예를 들어 ampicillin(항생제의 일종)이라는 일반명에 대해 각 회사에서는 모두 이 성분에 따라 약을 만들지만, 고유한 Amcill, 0mnipen, Penbritin, Polycillin 등의 각기 다른 상표를 붙이게 된다. |
||
| 영문 | semen analysis | 한글 | 정액 검사 |
|---|---|---|---|
| 설명 | 부부에게서 임신이 안되는 경우 실시하는 불임 검사중의 하나로 정액의 양, 정자의 운동성, 모양, 수 등을 측정한다. |
||
| APS | adenosine phosphosulfate; American Pain Society; American Pediatric Society; American Physiological ... |
|---|---|
| AES | acetone-extracted serum; American Electroencephalographic Society; American Encephalographic Society... |
| SA | salicylic acid; saline [solution]; salt added; sarcoidosis; sarcoma; scalenus anticus; secondary ame... |
| AR | absolute risk; accounts receivable; achievement ratio; actinic reticuloid [syndrome]; active resista... |
| CRI | Cardiac Risk Index; catheter-related infection; chronic renal insufficiency; chronic respiratory ins... |
| AOAC | Association of Official Analytical Chemists |
|---|---|
| AFS | Americal Fertility Society |
| ABS | American Brachytherapy Society |
| ACS | American Cancer Society |
| ASTM | American Society for Testing and Materials |
| American Cancer Society | <address, organisation> American Cancer Society, National Headquarters, 1599 Clifton Road, NE, Atlanta, GA 30329 USA. Tel: 00 1 404 320-3333 (05 Feb 1998) |
|---|---|
| medical missions, official | Travel by a group of physicians to a foreign country for the purpose of making a special study or of undertaking a special project of a short-term duration; not to be confused with missions and missionaries which covers permanent medical establishments and personnel maintained by religious organizations. (12 Dec 1998) |
| official | 1. Of or pertaining to an office or public trust; as, official duties, or routine. "That, in the official marks invested, you Anon do meet the senate." (Shak) 2. Derived from the proper office or officer, or from the proper authority; made or communicated by virtue of authority; as, an official statement or report. 3. <pharmacology> Approved by authority; sanctioned by the pharmacopoeia; appointed to be used in medicine; as, an official drug or preparation. Cf. Officinal. 4. Discharging an office or function. "The stomach and other parts official unto nutrition." (Sir T. Browne) Origin: L. Officialis: cf. F. Officiel. See Office, and cf. Official. Source: Websters Dictionary (01 Mar 1998) |
| official formula | A formula contained in the Pharmacopeia or the National Formulary. (05 Mar 2000) |
| retracted publication | Designation of an article or book retracted in whole or in part by an author or authors or an authorised representative. It identifies a citation previously published and now retracted through a formal issuance from the author, publisher, or other authorised agent, and is distinguished from retraction of publication, which identifies the citation retracting the original published item. (12 Dec 1998) |
| retraction of publication | A statement issued by one or more authors of an article or a book, withdrawing or disavowing acknowledgment of their participation in performing research or writing the results of their study. In indexing, the retraction is sent to the editor of the publication in which the article appeared and is published under the rubric "retraction" or in the form of a letter. This publication type designates the author's statement of retraction: it should be differentiated from retracted publication which labels the retracted publication. (12 Dec 1998) |
| publication bias | The influence of study results on the chances of publication and the tendency of investigators, reviewers, and editors to submit or accept manuscripts for publication based on the direction or strength of the study findings. Publication bias has an impact on the interpretation of clinical trials and meta-analyses. Bias can be minimised by insistence by editors on high-quality research, thorough literature reviews, acknowledgement of conflicts of interest, modification of peer review practices, etc. (12 Dec 1998) |
| duplicate publication | Simultaneous or successive publishing of identical or near- identical material in two or more different sources without acknowledgment. It differs from reprinted publication in that a reprint cites sources. It differs from plagiarism in that duplicate publication is the product of the same authorship while plagiarism publishes a work or parts of a work of another as one's own. The designation given an article or book of identical or nearly identical material published simultaneously or successively with the material previously published elsewhere, without acknowledgment. (12 Dec 1998) |
| absolute risk | <statistics> The excess risk due to exposure to a specific hazard (disease, injury, etc.) (15 Jan 1998) |
| acceptable risk | <statistics> This relates to the potential for suffering disease or injury that will be tolerated by an individual, group, or society in exchange for the benefits of using a substance or process that will cause such disease or injury. Acceptability of risk depends on scientific data, social, economic, and political factors, and on the perceived benefits arising from a chemical or process that creates the risk in question. (15 Jan 1998) |
| attributable risk | The rate of a disease or other outcome in exposed individuals that can be attributed to the exposure. (05 Mar 2000) |
| cardiac risk | A term to describe overall risk of developing heart disease (blockage of the coronary arteries). Typical risk factors include: diabetes, high blood pressure, prior heart attack, high cholesterol, obesity, smoking and a family history for heart attacks in parents or siblings. (27 Sep 1997) |
| recurrence risk | In medical genetics, the recurrence risk is the chance that a genetic (inherited) disease present in the family will recur in that family and affect another person (or persons). It is the chance of lightning striking twice (or thrice, etc.). (12 Dec 1998) |
| glaucoma, risk factors | If you belong to a high-risk group for glaucoma, have your eyes examined through dilated pupils every 2 years by an eye care professional. High-risk groups include everyone with a family history of glaucoma, everyone over the age of 60 and any Black over the age of 40. (Among Blacks, studies show that glaucoma is: 5 times more likely to occur in Blacks than in Whites and about 4 times more likely to cause blindness in Blacks than in Whites). (12 Dec 1998) |
| relative risk | <epidemiology> The proportion of diseased people amongst those exposed to the relevant risk factor divided by the proportion of diseased people amongst those not exposed to the risk factor. This should be used in those cohort studies where those with and without disease are followed to observe which individuals become diseased. (05 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|